These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17455201)

  • 1. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant.
    Browning BL; Huebner C; Petermann I; Demmers P; McCulloch A; Gearry RB; Barclay ML; Shelling AN; Ferguson LR
    Inflamm Bowel Dis; 2007 Sep; 13(9):1069-76. PubMed ID: 17455201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility.
    Lin Z; Hegarty JP; Berb A; Wang Z; Kelly AA; Wang Y; Poritz LS; Wu R; Koltun WA
    Swiss Med Wkly; 2011; 141():w13290. PubMed ID: 22065243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease.
    Li Y; Chen P; Sun J; Huang J; Tie H; Li L; Li H; Ren G
    Sci Rep; 2016 Sep; 6():33550. PubMed ID: 27633114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.
    Pearce AV; Fisher SA; Prescott NJ; Onnie CM; Pattni R; Green P; Forbes A; Mansfield J; Sanderson J; Schreiber S; Lewis CM; Mathew CG
    Int J Colorectal Dis; 2007 Apr; 22(4):419-24. PubMed ID: 16944184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
    Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J
    Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men.
    Lin Z; Poritz L; Franke A; Li TY; Ruether A; Byrnes KA; Wang Y; Gebhard AW; MacNeill C; Thomas NJ; Wu R; Schreiber S; Koltun WA
    Dis Markers; 2009; 27(5):193-201. PubMed ID: 20037206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
    Lakatos PL; Fischer S; Claes K; Kovacs A; Molnar T; Altorjay I; Demeter P; Tulassay Z; Palatka K; Papp M; Rutgeerts P; Szalay F; Papp J; Vermeire S; Lakatos L;
    Inflamm Bowel Dis; 2006 May; 12(5):362-8. PubMed ID: 16670524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DLG5 R30Q variant with inflammatory bowel disease.
    Daly MJ; Pearce AV; Farwell L; Fisher SA; Latiano A; Prescott NJ; Forbes A; Mansfield J; Sanderson J; Langelier D; Cohen A; Bitton A; Wild G; Lewis CM; Annese V; Mathew CG; Rioux JD
    Eur J Hum Genet; 2005 Jul; 13(7):835-9. PubMed ID: 15841097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
    Biank V; Friedrichs F; Babusukumar U; Wang T; Stoll M; Broeckel U; Kugathasan S
    Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
    Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
    Falvey JD; Bentley RW; Merriman TR; Hampton MB; Barclay ML; Gearry RB; Roberts RL
    World J Gastroenterol; 2013 Oct; 19(39):6656-64. PubMed ID: 24151396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
    Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
    Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population.
    Ferguson LR; Browning BL; Huebner C; Petermann I; Shelling AN; Demmers P; McCulloch A; Gearry RB; Barclay ML; Philpott M
    Dig Liver Dis; 2008 Sep; 40(9):723-30. PubMed ID: 18394979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The R30Q DLG5 variant is not associated with celiac disease or inflammatory bowel disease in the Spanish population.
    Dema B; Fernández-Arquero M; Maluenda C; Polanco I; Figueredo MA; De La Concha EG; Urcelay E; Núñez C
    Tissue Antigens; 2011 Jan; 77(1):62-4. PubMed ID: 20796250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
    Ferraris A; Torres B; Knafelz D; Barabino A; Lionetti P; de Angelis GL; Iacono G; Papadatou B; D'Amato G; Di Ciommo V; Dallapiccola B; Castro M
    Inflamm Bowel Dis; 2006 May; 12(5):355-61. PubMed ID: 16670523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.
    Cucchiara S; Latiano A; Palmieri O; Staiano AM; D'Incà R; Guariso G; Vieni G; Rutigliano V; Borrelli O; Valvano MR; Annese V
    World J Gastroenterol; 2007 Feb; 13(8):1221-9. PubMed ID: 17451203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association.
    Browning BL; Huebner C; Petermann I; Gearry RB; Barclay ML; Shelling AN; Ferguson LR
    Am J Gastroenterol; 2007 Nov; 102(11):2504-12. PubMed ID: 17850411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFSF15 is an ethnic-specific IBD gene.
    Picornell Y; Mei L; Taylor K; Yang H; Targan SR; Rotter JI
    Inflamm Bowel Dis; 2007 Nov; 13(11):1333-8. PubMed ID: 17663424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.